Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis.

Selzman CH, Netea MG, Zimmerman MA, Weinberg A, Reznikov LL, Grover FL, Dinarello CA.

J Thorac Cardiovasc Surg. 2003 Sep;126(3):688-93.

2.

Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation.

Miller SA, Selzman CH, Shames BD, Barton HA, Johnson SM, Harken AH.

J Surg Res. 2000 May 1;90(1):76-81.

PMID:
10781378
3.

Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60.

Hirono S, Dibrov E, Hurtado C, Kostenuk A, Ducas R, Pierce GN.

Circ Res. 2003 Oct 17;93(8):710-6. Epub 2003 Sep 18.

PMID:
14500333
4.

In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells.

Quinn TC, Gaydos CA.

Am Heart J. 1999 Nov;138(5 Pt 2):S507-11.

PMID:
10539860
6.

Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae.

Maass M, Gieffers J, Solbach W.

Herz. 2000 Mar;25(2):68-72.

PMID:
10829241
7.

Chlamydia pneumoniae and atherosclerosis.

Campbell LA, Kuo CC.

Semin Respir Infect. 2003 Mar;18(1):48-54. Review.

PMID:
12652454
8.
9.

Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells.

Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC.

Infect Immun. 1996 May;64(5):1614-20.

10.

Acute-phase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus.

Verkerk MS, Visseren FL, Paul Bouter K, Diepersloot RJ.

Eur J Clin Invest. 2003 Aug;33(8):720-5.

PMID:
12864783
11.

Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice.

Hauer AD, de Vos P, Peterse N, ten Cate H, van Berkel TJ, Stassen FR, Kuiper J.

Cardiovasc Res. 2006 Jan;69(1):280-8. Epub 2005 Aug 19.

PMID:
16112098
12.

Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.

Rothstein NM, Quinn TC, Madico G, Gaydos CA, Lowenstein CJ.

J Infect Dis. 2001 Jan 15;183(2):232-238. Epub 2000 Dec 13.

PMID:
11120929
13.

Chlamydia pneumoniae facilitates monocyte adhesion to endothelial and smooth muscle cells.

Kaul R, Wenman WM.

Microb Pathog. 2001 Mar;30(3):149-55.

PMID:
11273740
14.

Growth in vascular cells and cytokine production by Chlamydia pneumoniae.

Gaydos CA.

J Infect Dis. 2000 Jun;181 Suppl 3:S473-8. Review.

PMID:
10839742
15.

Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells.

Yang X, Coriolan D, Schultz K, Golenbock DT, Beasley D.

Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2308-14. Epub 2005 Sep 22.

PMID:
16179594
16.

Chlamydia pneumoniae and vascular disease.

Gibbs RG, Carey N, Davies AH.

Br J Surg. 1998 Sep;85(9):1191-7. Review.

PMID:
9752857
17.

Atherosclerosis: lipid infiltration or Chlamydia pneumoniae infection?

Shor A.

Circulation. 2002 Oct 29;106(18):e135-6; disscussion e135-6. No abstract available.

PMID:
12403680
18.

Infection with Chlamydia pneumoniae and atherosclerosis: a review.

Movahed MR.

J S C Med Assoc. 1999 Aug;95(8):303-8. Review.

PMID:
10478518
19.

Role of Chlamydia pneumoniae-infected macrophages in atherosclerosis developments of the carotid artery.

Kuroda S, Kobayashi T, Ishii N, Ikeda J, Shinohe Y, Houkin K, Iwasaki Y, Nagashima K.

Neuropathology. 2003 Mar;23(1):1-8.

PMID:
12722920
20.

Chlamydia pneumoniae and atherosclerosis.

Ouchi K.

Jpn J Infect Dis. 1999 Dec;52(6):223-7. Review.

PMID:
10738358

Supplemental Content

Support Center